The use of tripeptides for lead discovery of 5-HT4 receptor ligands

Protein and Peptide Letters

Volumn 16, Issue 7, 2009, Pages 805-809

  Hanna Elias, A ^a   Thompson, P E ^a   Manallack, D T ^a   Irving, H R ^a   Coupar, I M ^a   Berque Bestel, I ^b,c   Iskander, M N ^a  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c INSERM U869   (France)

Author keywords

5 HT; 5 HT4; Molecular docking; Radioligand binding; Serotonin; Tripeptide

Indexed keywords

EID: 67849083427     PISSN: 09298665     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986609788681805     Document Type: Article

References (21)

1. Takahashi, N.; Hamaue, N.; Kuronuma, N.; Yoshihara, T.; Ando, S.; Hirafuji, M.; Endo, T.; Senjo, M.; Parvez, S.H.; Minami, M. Salivary concentration of 5-hydroxytryptamine in patients with bulimia nervosa. Biogenic. Amines, 2004, 18, 361-368.
2. Firk, C.; Markus, C.R. Review: Serotonin by stress interaction: A susceptibility factor for the development of depression? J. Psychopharmacol., 2007, 21, 538-544.
3. Van Praag, H.M. Anxiety and increased aggression as pacemakers of depression. Acta Psychiatr. Scand. Suppl., 1998, 393, 81-88.
4. Verge, D.; Calas, A. Serotoninergic neurons and serotonin receptors: gains from cytochemical approaches. J. Chem. Neuroanat., 2000, 18, 41-56.
5. Evans, B.W.; Clark, W.K.; Moore, D.J.; Whorwell, P.J. Tegaserod for the treatment of irritable bowel syndrome and chronic constipation. Cochrane. Database Syst. Rev., 2007, CD003960.
6. Ruth, M.; Hamelin, B.; Rohss, K.; Lundell, L. The effect of mosapride, a novel prokinetic, on acid reflux variables in patients with gastro-oesophageal reflux disease. Aliment. Pharmacol. Ther., 1998, 12, 35-40.
7. Whitehead, W.E.; Engel, B.T.; Schuster, M.M. Irritable bowel syndrome: physiological and psychological differences between diarrhea-predominant and constipation-predominant patients. Dig. Dis. Sci., 1980, 25, 404-413.
8. Tonini, M.; Candura, S.M. 5-HT4 receptor agonists and bladder disorders. Trends Pharmacol. Sci., 1996, 17, 314-316.
9. Kamm, M.A. Review article: the complexity of drug development for irritable bowel syndrome. Aliment. Pharmacol. Ther., 2002, 16, 343-351.
10. 4 receptor by site-directed mutagenesis and molecular modeling. Br. J. Pharmacol., 2000, 130, 527-538.
11. Hedner, E.; Sjögren, M.; Frändberg, P.A.; Johansson, T.; Göransson, U.; Dahlström, M.; Jonsson, P.; Nyberg, F.; Bohlin, L. Brominated Cyclodipeptides from the Marine Sponge Geodia barretti as Selective 5-HT Ligands. J. Nat. Prod., 2006, 69, 1421-1424.
12. Mialet, J.; Dahmoune, Y.; Lezoualc'h, F.; Berque-Bestel, I.; Eftekhari, P.; Hoebeke, J.; Sicsic, S.; Langlois, M.; Fischmeister, R. Exploration of the ligand binding site of the human 5-HT(4) receptor by site-directed mutagenesis and molecular modeling. Br. J. Pharmacol., 2000, 130, 527-538.
13. King, D.S.; Fields, C.G.; Fields, G.B. A cleavage method which minimizes side reactions following Fmoc solid phase peptide synthesis. Int. J. Pept. Protein Res., 1990, 36, 255-266.
14. 3H]-GR113808 labels 5-HT4 receptors in the human and guinea-pig brain. Neuroreport, 1993, 4, 1239-1242. (Pubitemid 23289202)
15. Coupar, I.M.; Desmond, P.V.; Irving, H. Human 5-HT4 and 5-HT7 receptor splice variants: Are they important? Curr. Neuropharmacol., 2007, 5, 224-231.
16. Buchheit, K.H.; Gamse, R.; Giger, R.; Hoyer, D.; Klein, F.; Kloppner, E.; Pfannkuche, H.J.; Mattes, H. The serotonin 5-HT4 receptor. 2. Structure-activity studies of the indole carbazimidamide class of agonists. J. Med. Chem., 1995, 38, 2331-2338.
17. Rasmussen, S.G.F.; Choi, H.-J.; Rosenbaum, D.M.; Kobilka, T.S.; Thian, F.S.; Edwards, P.C.; Burghammer, M.; Ratnala, V.R.P.; Sanishvili, R.; Fischetti, R.F.; Schertler, G.F.X.; Weis, W.I.; Kobilka, B.K. Crystal structure of the human beta2 adrenergic Gprotein-coupled receptor. Nature, 2007, 450, 383-387.
18. Rosenbaum, D.M.; Cherezov, V.; Hanson, M.A.; Rasmussen, S.G.F.; Thian, F.S.; Kobilka, T.S.; Choi, H.-J.; Yao, X.-J.; Weis, W.I.; Stevens, R.C.; K., K.B. GPCR engineering yields highresolution structural insights into beta2-adrenergic receptor function. Science, 2007, 318, 1266-1273.
19. 1-adrenergic G-protein coupled receptor. Nature, 2008, 454, 486-491.
20. 4 receptor mediating tachycardia in piglet isolated right atrium. Br. J. Pharmacol., 1993, 110, 1023-1030.
21. Cohen, N.C. Structure-based drug design and the discovery of aliskiren (Tekturna): perseverance and creativity to overcome a R&D pipeline challenge. Chem. Biol. Drug Des., 2007, 70, 557-565.